As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

We want you to hear the music and voice. We don’t want you to hear the box," says Geoff Steadman of Telos Alliance.

VANCOUVER, BC / ACCESS Newswire / November 11, 2025 / (TSX:NANO)(OTCQB:NNOMF)(Frankfurt:LBMB) Business Operational Highlights Newly installed proprietary agitator in full-scale One-Pot™ reactor at ...

Total gold demand, including OTC, grew 3% y/y to 1,313t, the highest quarterly total in our data series. Read more here.

The Tata Nexon retained its position as the best-selling car in October 2025, driven by strong SUV demand and wide powertrain ...

Phalanx raises manipulation costs by orders of magnitude, making such attacks economically impossible. Verifiable delay ...

Google's report of novel AI-enabled malware in the wild is a game changer if these capabilities are now being picked up by ...

The South African citrus performance represents a 19 percent increase from the initial estimate released back in April, and a ...

As the self-quantification movement matures, users are expanding beyond physical tracking to assess how they think, decide, ...